LAURUS LABS
Back to Balance Sheet
|
LAURUS LABS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹1,193 Cr | ₹1,159 Cr | ₹1,179 Cr | ₹928 Cr | ₹693 Cr |
What is the latest Total Non-Current Liabilities ratio of LAURUS LABS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹1,193 Cr |
| Mar2024 | ₹1,159 Cr |
| Mar2023 | ₹1,179 Cr |
| Mar2022 | ₹928 Cr |
| Mar2021 | ₹693 Cr |
How is Total Non-Current Liabilities of LAURUS LABS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,193 Cr | 2.95 | |
| Mar2024 | ₹1,159 Cr | -1.72 | |
| Mar2023 | ₹1,179 Cr | 27.10 | |
| Mar2022 | ₹928 Cr | 33.94 | |
| Mar2021 | ₹693 Cr | - | |
Compare Total Non-Current Liabilities of peers of LAURUS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LAURUS LABS | ₹51,322.9 Cr | -0.4% | -15.8% | 62% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,615.0 Cr | 4% | -4.9% | -2.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,943.0 Cr | 1.1% | -9.3% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,336.0 Cr | -1.3% | -3.7% | 24% | Stock Analytics | |
| CIPLA | ₹107,499.0 Cr | 1.5% | -9.3% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,590.0 Cr | 5% | -0.1% | 3.3% | Stock Analytics | |
LAURUS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LAURUS LABS | -0.4% |
-15.8% |
62% |
| SENSEX | 3.5% |
-1.7% |
7.8% |
You may also like the below Video Courses